Flynt, Amy
18  results:
Search for persons X
?
1

Phase 3 study evaluating the safety and efficacy of oteseco..:

Martens, Mark G. ; Maximos, Bassem ; Degenhardt, Thorsten...
American Journal of Obstetrics and Gynecology.  227 (2022)  6 - p. 880.e1-880.e11 , 2022
 
?
2

RF28 | PSUN198 The Dramatic Fat Mass Loss Caused by Bimagru..:

Klickstein, Lloyd ; Flynt, Amy ; Edgerton, Dawn..
Journal of the Endocrine Society.  6 (2022)  Supplement_1 - p. A37-A38 , 2022
 
?
5

Evaluation of the Safety, Pharmacokinetics, Pharmacodynamic..:

Sloan‐Lancaster, Joanne ; Raddad, Eyas ; Deeg, Mark A....
Clinical Pharmacology in Drug Development.  7 (2018)  7 - p. 759-772 , 2018
 
?
 
?
7

LY3045697: Results from two randomized clinical trials of a..:

Sloan-Lancaster, Joanne ; Raddad, Eyas ; Flynt, Amy...
Journal of the Renin-Angiotensin-Aldosterone System.  18 (2017)  3 - p. 147032031771788 , 2017
 
?
13

P-010 Tumor-intrinsic features associated with progression-..:

Stong, Nicholas ; Thompson, Ethan ; Xu, Amy...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S38 , 2023
 
?
14

P-179 Altered lipid metabolism in IMiD/CELMoD resistant mul..:

Bird, Sarah ; Xu, Yitao ; Sialana, Fernando...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S134 , 2023
 
?
15

P-016: Tumor profiling of idecabtagene vicleucel (ide-cel, ..:

Martin, Nathan ; Xu, Amy ; Stong, Nicholas...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S44-S45 , 2022
 
1-15